Recital 2, Decision_act (EU) 2019/1951

In force

The approval of tebuconazole for use in biocidal products of product-type 8 will expire on 31 March 2020. On 27 September 2018, an application was submitted in accordance with Article 13(1) of Regulation (EU) No 528/2012 for the renewal of the approval of tebuconazole.